Professor Malcolm Mason
Prosiectau fel Prif Ymchwiliwr
1 o 2
- Investigation of P53 role in immunogenic death in breast tumour cells (01.09.2010 - 30.05.2011)
- Optimisation of positron emission tomography based target volume delineation in head and neck radiotherapy (01.09.2011 - 31.08.2014)
- Proposal for tissue processing and clinical data collection (04.09.2006 - 31.10.2012)
- Prostate cancer immunity during androgen deprivation and the role of hepatocyte growth factor (01.04.2006 - 30.09.2011)
- Tumour stroma in prostate cancer: development and immunosuppressive effects (01.10.2011 - 30.06.2017)
Prosiectau fel Cyd-Ymchwiliwr
1 o 5
- Add-Aspirin (01.03.2015 - 31.03.2027)
- Assessment of patient dose using novel radioisotopes in molecular targeted radiotherapy (31.03.2010 - 30.06.2012)
- Cancer Genetics Biomedical Research Unit (31.03.2011 - 31.05.2015)
- Cancer metastasis modelling platform (01.10.2015 - 30.09.2016)
- Cancer Research UK Cardiff Centre (01.04.2014 - 31.03.2017)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany